Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
about
Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseasesAdvancements in Developing Strategies for Sterilizing and Functional HIV Cures.Genome Editing and Muscle Stem Cells as a Therapeutic Tool for Muscular Dystrophies.Induced Pluripotent Stem Cells Meet Genome EditingCRISPR/Cas9-The ultimate weapon to battle infectious diseases?Efficient Production of Gene-Modified Mice using Staphylococcus aureus Cas9.Genome editing: progress and challenges for medical applications.CRISPR as a strong gene editing tool.Mitochondrial Modification Techniques and Ethical Issues.Disease Resistance and the Definition of Genetic Enhancement.Developmental history and application of CRISPR in human disease.Quantitative assessment of timing, efficiency, specificity and genetic mosaicism of CRISPR/Cas9-mediated gene editing of hemoglobin beta gene in rhesus monkey embryos.The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.A history of genome editing in mammals.Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate.Highly efficient base editing in human tripronuclear zygotes.Highly efficient and precise base editing in discarded human tripronuclear embryos.A transatlantic perspective on 20 emerging issues in biological engineering.Correction of β-thalassemia mutant by base editor in human embryos.Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.The Future of CRISPR Applications in the Lab, the Clinic and Society.CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.The evolution of CRISPR/Cas9 and their cousins: hope or hype?Genome editing reveals a role for OCT4 in human embryogenesis.In case you missed it: the Prenatal Diagnosis editors bring you the most significant advances of 2016.CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE.Generation of Genetically Modified Mice through the Microinjection of Oocytes.[A new milestone in human embryo editing].The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Legal issues regarding gene editing at the beginning of life: an EU perspective.Renaissance, reinvention, or rhetoric: mitochondria in reproductive medicine 2017.L'éthique de la modification du génome en clinique : une dose de réalisme pour les leaders en santé.The ethics of genome editing in the clinic: A dose of realism for healthcare leaders.Better beings?The illusion of control in germline-engineering policy.Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".[CRISPR-Cas system as molecular scissors for gene therapy].National Academies relax stance on germline edits.Crossing the germline: CRISPR-Cas9 and our responsibility as reproductive endocrinology and infertility physicians.
P2860
Q26744780-01883399-6212-45C8-A3AF-5F1B92ACC515Q33654409-20E2063F-2C21-4BA8-9FAC-7EB7FA8CAD28Q33729585-5C349494-F9CF-4763-9281-35BA19EC5B95Q34525438-EA8630E4-BCA7-4C18-BF46-DDA1BD1140ACQ36196813-987449E8-5661-4B47-A685-B8E3E97E5852Q37227736-B7F565CB-0AFA-492F-B5A5-5DF4399BEB00Q37417137-114291E4-F794-4893-8D25-F11513DD2579Q37656508-4B8BBA66-B4DC-487A-B2CE-F46E5C3F3D35Q37729935-E61AE245-612C-47E4-BE4B-F3B544A4D510Q37742928-368AFB90-D6A8-4CDD-B227-929B17EEF6A4Q38669948-A164C1FD-EF6E-4273-BD9E-0353F8A8DED8Q38819336-09A561A2-E65F-4BD2-BE92-31C73CB99FB1Q39260698-B153F0E3-46A6-4F6C-B1F6-E6E2C05D004AQ39356164-544A4024-FCE5-472A-8538-3C9BD8AD7B6FQ41067562-D5D5394C-1755-4ED0-802F-14A59FDB9A04Q42651117-1ADDEEF0-1818-4D45-B9D8-DAD4457B107AQ42704638-A76A9DDB-92AD-495C-A6FA-197209BA5961Q44877018-BFCE0314-0998-4FA6-B9E8-D3EA37FD1F53Q46124667-80FDAF7E-C7CA-4418-B316-9F46B4D85EAEQ46208205-D7E5BBB4-B677-4F10-AF96-D5B802FEF407Q46262974-2773AE94-62A4-49C7-8F88-D1432D6C9237Q46522290-CB6E431C-B3F5-480E-95D1-E2098F588760Q47552046-1306EDC9-82E4-4AD3-9CE8-5068CE96D0F6Q47625824-18573943-A18C-4E10-8F8C-DF8B25F0AB94Q47886340-A50127D1-9429-44D7-8364-87B06A2B22E0Q48174947-1B21FDBA-FCED-46BE-B4C9-49760ABE4BEBQ48257215-E2E15B35-8579-4FBC-B07D-C01B5BC2A1E8Q48518339-17E6088E-3570-4A89-A832-914DBC1D1CC1Q48595452-25BAF430-ABAE-4379-9BC5-B5C67BA37A1CQ49432567-AF5D2C91-6BA5-4CDB-83D0-93922F03CC1EQ49612922-6CB9B16A-235E-4B15-B5B7-01B76218C935Q49685598-7D372F66-639E-4CA3-A214-18CEB22C9A8CQ49997291-46517FE1-FAD9-43F4-9E84-F3041B898213Q49997295-5E535807-08EF-4535-B084-99E5179B7875Q50093502-033C9937-3E13-4B06-85E9-77C30B4815EBQ50849035-166E3BE4-FBAE-4811-997F-EED77E37FD64Q50983533-6B154D92-00AD-423A-8B35-7AB26805F381Q52426754-C278E003-F031-423C-84C2-46AEBE833102Q52427438-498EE1D9-4B7D-4BB0-899D-A29C8CA71C4EQ52429234-2C96DC49-71DC-431C-92BE-E14504B7D5CD
P2860
Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Introducing precise genetic mo ...... R/Cas-mediated genome editing.
@en
type
label
Introducing precise genetic mo ...... R/Cas-mediated genome editing.
@en
prefLabel
Introducing precise genetic mo ...... R/Cas-mediated genome editing.
@en
P2093
P2860
P1476
Introducing precise genetic mo ...... R/Cas-mediated genome editing.
@en
P2093
Xiangjin Kang
Xiaofang Sun
Xingcheng Gao
Yaoyong Chen
Yuling Huang
P2860
P2888
P304
P356
10.1007/S10815-016-0710-8
P577
2016-04-06T00:00:00Z